STTR [Phase I]: Target Identification for Novel Small Molecule Therapeutic for Alzheimer's Disease

Grants and Contracts Details

StatusFinished
Effective start/end date10/15/168/31/17

Funding

  • CoPlex Therapeutics LLC: $54,251.00